Kevin DiCicco, who turned a stray dog into the star of ‘Air Bud,’ has died of COPD, leaving behind one of the most unlikely ...

Living with COPD Support & Education Meeting Did you know that approximately 16 million Americans are affected by Chronic Obstructive Pulmonary Disease (COPD)?  This chronic condition restricts air ...

The treatment, tozorakimab, succeeded where other similar therapies failed and could help a broader group of COPD patients ...

Vida Health, a value-based, virtual cardiometabolic provider that enables patients to manage metabolic instability, today ...

Tozorakimab is an investigational monoclonal antibody designed to bind and inhibit interleukin-33, an alarmin cytokine.

AstraZeneca shares rose after the company said a drug candidate met the primary goal in two late-stage trials for a deadly lung disease, clearing the path to seek approval from regulators. The U.K.

AstraZeneca jumps 4% after COPD drug wins Phase 3 trials. Tozorakimab success seen as rare win in tough COPD drug race.

The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.

Tozorakimab met the primary goal in two late-stage clinical trials, reducing the rate at which patients’ symptoms worsened, ...

TrumpRx is adding 3 more products, 2 for diabetes and 1 for COPD, to its site as it continues efforts to lower drug prices.

GD analyst, Vinie Varkey notes that tozorakimab could capture a "significant patient share" as an add-on therapy in COPD.